{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:43:20Z","timestamp":1761662600359,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1053\/ajkd.2000.19929","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T21:11:45Z","timestamp":1206047505000},"page":"S31-S38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S3","title":["Complications of chronic renal insufficiency: Beyond cardiovascular disease"],"prefix":"10.1053","volume":"36","author":[{"given":"Paul M.","family":"Zabetakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen R.","family":"Nissenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2000.19929_bib1","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1681\/ASN.V7122616","article-title":"Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study","volume":"7","author":"Modification of Diet in Renal Disease Study Group","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2000.19929_bib2","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1681\/ASN.V1081793","article-title":"Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States","volume":"10","author":"Obrador","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2000.19929_bib3","first-page":"734","article-title":"Dietary protein restriction in patients with chronic renal failure","volume":"29","author":"Mitch","year":"1991","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.19929_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ajcn\/64.2.125","article-title":"Comparison of five body composition methods in peritoneal dialysis patients","volume":"64","author":"Stall","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/ajkd.2000.19929_bib5","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/ki.1994.475","article-title":"Morbidity and mortality in dialysis patients","volume":"46","author":"Port","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.19929_bib6","first-page":"32","article-title":"Comorbid conditions and correlations with mortality risk among 3399 incident hemodialysis patients","volume":"20","author":"US","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2000.19929_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0272-6386(13)80002-9","article-title":"Canadian hemodialysis morbidity study","volume":"19","author":"Churchill","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2000.19929_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ki.1996.323","article-title":"Nutrition in end-stage renal disease","volume":"50","author":"Ikizer","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.19929_bib9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0272-6386(12)81075-4","article-title":"Effect of nutrition on morbidity and mortality in maintenance dialysis patients","volume":"24","author":"Kopple","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2000.19929_bib10","first-page":"243","article-title":"Nutritional monitoring techniques in dialysis: Can routine monitoring impact outcome?","volume":"43","author":"Zabetakis","year":"1997","journal-title":"ASAIO J"},{"key":"10.1053\/ajkd.2000.19929_bib11","first-page":"338","article-title":"Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine","volume":"1","author":"Bright","year":"1836","journal-title":"Guys Hosp Rep"},{"key":"10.1053\/ajkd.2000.19929_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archinte.1922.00110120136009","article-title":"The anemia of chronic nephritis","volume":"30","author":"Brown","year":"1922","journal-title":"Arch Intern Med"},{"key":"10.1053\/ajkd.2000.19929_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00000441-193302000-00004","article-title":"Anemia in azotemia","volume":"185","author":"Parsons","year":"1933","journal-title":"Am J Med Sci"},{"key":"10.1053\/ajkd.2000.19929_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ajcp\/20.1.3","article-title":"Blood and bone marrow studies in renal disease","volume":"20","author":"Callen","year":"1950","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/ajkd.2000.19929_bib15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.1997.91","article-title":"Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure","volume":"51","author":"Erslev","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.19929_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0272-6386(12)80290-3","article-title":"Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients","volume":"18","author":"The","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2000.19929_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00041552-199503000-00008","article-title":"The use of recombinant human erythropoietin in predialysis patients","volume":"4","author":"Besarab","year":"1995","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/ajkd.2000.19929_bib18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0272-6386(89)80149-0","article-title":"The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: A double-blind, placebo-controlled trial","volume":"14","author":"Kleinman","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2000.19929_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/039139889401700402","article-title":"Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non-dialysis patients","volume":"17","author":"Kulzer","year":"1994","journal-title":"Int J Artif Organs"},{"key":"10.1053\/ajkd.2000.19929_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-110-2-108","article-title":"Recombinant human erythropoietin treatment in pre-dialysis patients: A double-blind placebo-controlled trial","volume":"110","author":"Lim","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2000.19929_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000186956","article-title":"Effectiveness and safety of recombinant human erythropoietin in predialysis patients","volume":"61","author":"Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients","year":"1992","journal-title":"Nephron"},{"issue":"suppl 2","key":"10.1053\/ajkd.2000.19929_bib22","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/ndt\/14.suppl_2.66","article-title":"How should anaemia be managed in pre-dialysis patients?","volume":"14","author":"Levin","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2000.19929_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-196202000-00001","article-title":"Metabolic studies of renal osteodystrophy: I. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia, and hyperparathyroidism complicating chronic uremia and the osteomalacia of the adult","volume":"41","author":"Stanbury","year":"1962","journal-title":"Fanconi syndrome Medicine (Baltimore)"},{"key":"10.1053\/ajkd.2000.19929_bib24","first-page":"1","article-title":"Treatment of renal glomerular osteodystrophy","volume":"30","author":"Dent","year":"1961","journal-title":"QJM"},{"key":"10.1053\/ajkd.2000.19929_bib25","first-page":"2187","article-title":"Renal osteodystrophy","author":"Llach","year":"1996"},{"key":"10.1053\/ajkd.2000.19929_bib26","first-page":"S71","article-title":"Prevention of metabolic bone disease in the pre-end-stage renal disease setting","volume":"9","author":"Coburn","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2000.19929_bib27","first-page":"1363","article-title":"Investigations on the pathogenesis of hyperchloremic acidosis in chronic renal diseases","volume":"7","author":"Raszeja-Wanic","year":"1968","journal-title":"Pol Med J"},{"key":"10.1053\/ajkd.2000.19929_bib28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.1979.03630470021010","article-title":"Serum electrolyte and acid-base composition: The influence of graded degrees of renal failure","volume":"139","author":"Widmer","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1053\/ajkd.2000.19929_bib29","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1177\/089686089501505S04","article-title":"Metabolic acidosis and uremia","volume":"15","author":"Walls","year":"1995","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2000.19929_bib30","first-page":"S78","article-title":"Catabolism in uremia: The impact of metabolic acidosis","volume":"9","author":"Franch","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2000.19929_bib31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ajcn\/28.9.1036","article-title":"Hypertriglyceridemia in patients with chronic renal insufficiency","volume":"28","author":"McCosh","year":"1975","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/ajkd.2000.19929_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000186303","article-title":"Lipid and apolipoprotein profiles of uremic dyslipoproteinemia\u2014Relation to renal function and dialysis","volume":"57","author":"Attman","year":"1991","journal-title":"Nephron"},{"key":"10.1053\/ajkd.2000.19929_bib33","first-page":"1981","article-title":"Renal and systemic manifestations of glomerular disease","author":"Anderson","year":"1996"},{"key":"10.1053\/ajkd.2000.19929_bib34","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","article-title":"Secondary hypertension in a blood pressure clinic","volume":"147","author":"Sinclair","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1053\/ajkd.2000.19929_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000413223","article-title":"Retinopathy in hypertension: Increased incidence in renoparenchymal disease","volume":"54","author":"Heidland","year":"1987","journal-title":"Contrib Nephrol"},{"key":"10.1053\/ajkd.2000.19929_bib36","first-page":"1433","article-title":"Nephrosclerosis","author":"Luke","year":"1993"},{"key":"10.1053\/ajkd.2000.19929_bib37","first-page":"S63","article-title":"Approach to volume control, cardiac preservation, and blood pressure control in the pre-end-stage renal disease patient","volume":"9","author":"Heinrich","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2000.19929_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/cs0640141","article-title":"Development of hypertension in renal disease","volume":"64","author":"Brod","year":"1983","journal-title":"Clin Sci"},{"key":"10.1053\/ajkd.2000.19929_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/01.HYP.5.4.545","article-title":"Elevated plasma catecholamines in hypertensives with primary glomerular diseases","volume":"5","author":"Ishii","year":"1983","journal-title":"Hypertension"},{"key":"10.1053\/ajkd.2000.19929_bib40","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ki.1985.203","article-title":"Norepinephrine-related mechanism in hypertension accompanying renal failure","volume":"28","author":"Schohn","year":"1985","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.19929_bib41","first-page":"147","article-title":"Increased levels of plasma renin, aldosterone, catecholamines and vasopressin in chronic ambulatory peritoneal dialysis (CAPD) patients","volume":"28","author":"Zabetakis","year":"1987","journal-title":"Clin Nephrol"},{"key":"10.1053\/ajkd.2000.19929_bib42","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.19929_bib43","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin converting enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.19929_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00041552-199709000-00014","article-title":"Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal disease","volume":"6","author":"Ruggenenti","year":"1997","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"suppl 3","key":"10.1053\/ajkd.2000.19929_bib45","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1053\/ajkd.1998.v32.pm9820471","article-title":"Hypertension in patients with chronic renal disease","volume":"5","author":"Mailloux","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2000.19929_bib46","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/ki.1995.236","article-title":"Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial","volume":"47","author":"The Diabetes Control and Complications Trial (DCCT) Research Group","year":"1995","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.19929_bib47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK","year":"1998","journal-title":"BMJ"},{"key":"10.1053\/ajkd.2000.19929_bib48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199307293290502","article-title":"The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus","volume":"329","author":"Reichard","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.19929_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: A randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1053\/ajkd.2000.19929_bib50","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/0140-6736(93)90816-Y","article-title":"Meta-analysis of the effects of intensive blood-glucose control on late complications of type I diabetes","volume":"341","author":"Wang","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/ajkd.2000.19929_bib51","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetics","volume":"329","author":"The Diabetes Control and Complications Trial (DCCT) Research Group:","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2000.19929_bib52","first-page":"1864","article-title":"Diabetic nephropathy","author":"Parving","year":"1996"},{"key":"10.1053\/ajkd.2000.19929_bib53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ndt\/15.5.650","article-title":"Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study","volume":"15","author":"Holland","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2000.19929_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","article-title":"Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin","volume":"34","author":"Levin","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2000.19929_bib55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end-stage renal disease","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.19929_bib56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0272-6386(96)90357-1","article-title":"Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention","volume":"27","author":"Levin","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2000.19929_bib57","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1046\/j.1523-1755.2000.00115.x","article-title":"Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada","volume":"57","author":"Murphy","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2000.19929_bib58","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0272-6386(00)70334-9","article-title":"Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure","volume":"35","author":"Hayashi","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2000.19929_bib59","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations","volume":"35","author":"Silverberg","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/ajkd.2000.19929_bib60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0272-6386(97)90335-8","article-title":"Cardiovascular effects of recombinant human erythropoietin in pre-dialysis patients","volume":"29","author":"Portoles","year":"1997","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638600434475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638600434475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:18:38Z","timestamp":1759454318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638600434475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0272638600434475"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2000.19929","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2000,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications of chronic renal insufficiency: Beyond cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2000.19929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}